The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study
Key facts
- Who runs it
- Shandong University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 300 people, planned
- Started
- Oct 2016
- Expected to end
- Oct 2031
- Type of study
- Interventional
- Treatments tested
- biopsy
- H. pylori eradication
- Record updated
- 14 October 2016
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients with H. pylori infection
- Aged 18-65 years
Who cannot take part
- Patients with gastrectomy, acute GI bleeding and advanced gastric cancer
- Conditions unsuitable for performance of gastroscopy, such as coagulopathy, impaired renal function
- Pregnancy or breastfeeding
- Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Helicobacter pylori (H. pylori) infection, affecting an estimated 50% of the global population, is a main cause of chronic gastritis, peptic ulcers and gastric cancer. By causing progressive damage to the stomach and may eventually result in gastric atrophy, H. pylori infection has been demonstrated to be responsible for more than 95% of gastric malignancies
The group in the trial
- H. pylori eradication cohortTreatment being tested
H. pylori eradication therapy comprising esomeprazole, amoxicillin,clarithromycin and colloidal bismuth pectin. If failed in eradicating H. pylori, a culture based antimicrobial susceptibility test will be used to guide H. pylori eradication.
Treatment: biopsy and H. pylori eradication
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT02933229, who can take part
- Record updated
- 14 October 2016